Intellectual and Developmental Disabilities Research Center

FACULTY

Szilagyi, Peter, M.D., M.P.H.

Research

Pediatrics, Clinical and Translational Research, Population Health, Community Health Engagement and Training

Appointments

  • Professor of Pediatrics
  • Pediatrics Leader
  • Child Health Research
  • Member, CTSI

Publications

  1. Szilagyi, MA, Szilagyi, PG. A Vision for Children in America. Acad Pediatr. 2024; :. doi: 10.1016/j.acap.2024.06.004. PubMed PMID:38851384 .
  2. Antoon, JW, Stopczynski, T, Amarin, JZ, Stewart, LS, Boom, JA, Sahni, LC et al.. Accuracy of Influenza ICD-10 Diagnosis Codes in Identifying Influenza Illness in Children. JAMA Netw Open. 2024;7 (4):e248255. doi: 10.1001/jamanetworkopen.2024.8255. PubMed PMID:38656577 PubMed Central PMC11043895.
  3. Clopper, BR, Zhou, Y, Tannis, A, Staat, MA, Rice, M, Boom, JA et al.. Medical Costs of Respiratory Syncytial Virus-Associated Hospitalizations and Emergency Department Visits in Children Aged Younger Than 5 Years: Observational Findings from the New Vaccine Surveillance Network, 2016-2019. J Pediatr. 2024;271 :114045. doi: 10.1016/j.jpeds.2024.114045. PubMed PMID:38561048 .
  4. Szilagyi, PG, Duru, OK, Casillas, A, Ong, MK, Vangala, S, Tseng, CH et al.. Text vs Patient Portal Messaging to Improve Influenza Vaccination Coverage: A Health System-Wide Randomized Clinical Trial. JAMA Intern Med. 2024;184 (5):519-527. doi: 10.1001/jamainternmed.2024.0001. PubMed PMID:38497955 PubMed Central PMC10949147.
  5. Moline, HL, Tannis, A, Toepfer, AP, Williams, JV, Boom, JA, Englund, JA et al.. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024. MMWR Morb Mortal Wkly Rep. 2024;73 (9):209-214. doi: 10.15585/mmwr.mm7309a4. PubMed PMID:38457312 PubMed Central PMC10932582.
Search PubMed